Clinical Trials Browser

Phase 2 × Neoplasms × Control Groups × Clear all

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Phase 2 Unknown

Arrhythmias, Cardiac, Heart Failure, Neoplasms